Read More Pharma Industry News Akeso gumokimab approval strengthens China biologics push as psoriasis market heats up Find out how Akeso’s gumokimab approval could reshape China’s psoriasis biologics market and boost its autoimmune drug strategy. byPallavi MadhirajuJune 12, 2026